Literature DB >> 32233846

Severe hypercalcaemia of primary hyperparathyroidism: Could giant adenoma be the real culprit rather than carcinoma?

S Gücek Haciyanli1, N Acar1, E Ö Gür1, S C Çelik1, S Karaıslı1, O N Dilek1, M Haciyanli1.   

Abstract

INTRODUCTION: Hypercalcaemic crisis is a rare manifestation of hyperparathyroidism and occurs in 1.6-6% of patients with primary hyperparathyroidism (pHPT). Although such high serum calcium levels (>14mg/dl) are attributed to malignancy, it is also associated with benign disease of the parathyroid glands. The aim of this study was to evaluate the clinical features and treatment modalities of patients with severe hypercalcaemia who underwent surgery for pHPT.
METHODS: The medical records of 537 patients who underwent parathyroidectomy in our department for pHPT between 2005 and 2019 were reviewed retrospectively. Twenty-four (4.4%) of the patients were described as having severe hypercalcaemia.
RESULTS: Among 24 patients, 71% were female and the mean age was 55.7 years (range: 40-71 years). The mean serum calcium level at time of diagnosis was 15.9mg/dl (range: 14-22.7mg/dl). According to postoperative pathology reports, solitary adenoma, parathyroid cancer and parathyromatosis were diagnosed with the rates of 87.5%, 8.3% and 4.1% respectively. The mean weight of the solitary parathyroid lesions was 14.9g (standard deviation: 8.9g, range: 4-38g). The mean longest diameter was 2.87cm (standard deviation: 1.4cm, range: 1-5.5cm). Serum calcium levels were within the normal range on the first postoperative day in 75% of the cases.
CONCLUSIONS: Severe hypercalcaemia is a rare but urgent condition of pHPT and requires prompt management. Accelerated surgery after adequate medical treatment should be performed. It is important to emphasise that giant adenoma, which is a benign disease, may be a more common cause of severe hypercalcaemia than carcinoma, unlike previously thought.

Entities:  

Keywords:  Adenoma; Giant; Hyperparathyroidism; Severe hypercalcaemia

Mesh:

Substances:

Year:  2020        PMID: 32233846      PMCID: PMC7374794          DOI: 10.1308/rcsann.2020.0039

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  15 in total

Review 1.  Clinical review 122: Parathyroid carcinoma.

Authors:  E Shane
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Parathyroidectomy for hypercalcemic crisis: 40 years' experience and long-term outcomes.

Authors:  Jennifer Cannon; John I Lew; Carmen C Solórzano
Journal:  Surgery       Date:  2010-08-30       Impact factor: 3.982

Review 3.  The diagnosis and management of asymptomatic primary hyperparathyroidism.

Authors:  Shonni J Silverberg; John P Bilezikian
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-09

Review 4.  Parathyroid cancer.

Authors:  Sandy H Fang; Geeta Lal
Journal:  Endocr Pract       Date:  2011 Mar-Apr       Impact factor: 3.443

Review 5.  Functioning parathyroid carcinoma: clinicopathologic features and rational treatment.

Authors:  T Obara; T Okamoto; M Kanbe; M Iihara
Journal:  Semin Surg Oncol       Date:  1997 Mar-Apr

6.  Calcium free hemodialysis: an effective therapy in hypercalcemic crisis--report of 4 cases.

Authors:  W Kaiser; G Biesenbach; R Kramar; J Zazgornik
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

7.  Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH.

Authors:  Daniel Calva-Cerqueira; Brian J Smith; Michelle L Hostetler; Geeta Lal; Yusuf Menda; Thomas M O'Dorisio; James R Howe
Journal:  J Am Coll Surg       Date:  2007-10       Impact factor: 6.113

8.  Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy.

Authors:  Roy Phitayakorn; Christopher R McHenry
Journal:  J Am Coll Surg       Date:  2008-02-21       Impact factor: 6.113

9.  Do giant parathyroid adenomas represent a distinct clinical entity?

Authors:  Philip M Spanheimer; Andrew J Stoltze; James R Howe; Sonia L Sugg; Geeta Lal; Ronald J Weigel
Journal:  Surgery       Date:  2013-08-23       Impact factor: 3.982

10.  Giant parathyroid adenoma: differential aspects compared to parathyroid carcinoma.

Authors:  Marta Araujo Castro; Ainhoa Abad López; Luz Martín Fragueiro; Nuria Palacios García
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-05-06
View more
  1 in total

Review 1.  Primary hyperparathyroidism-related giant parathyroid adenoma (Review).

Authors:  Adina Ghemigian; Alexandra Ioana Trandafir; Eugenia Petrova; Mara Carsote; Ana Valea; Alexandru Filipescu; Ana-Maria Oproiu; Florica Sandru
Journal:  Exp Ther Med       Date:  2021-11-26       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.